Literature DB >> 7201980

Bronchopulmonary torulopsosis.

R Patterson, B S Samuels, J J Phair, M Roberts.   

Abstract

A patient had clinical and radiographic findings suggestive of allergic bronchopulmonary aspergillosis. Further studies excluded this diagnosis but indicated that the patient's respiratory disease was due to the yeast Torulopsis glabrata, usually nonpathogenic in normal human hosts. The patient had no evidence of invasive disease. Total serum IgE was elevated but IgE antibody against T. glabrata could not be demonstrated by skin test or radioimmunoassay. Demonstration of elevated IgG antibody against T. glabrata antigen by radioimmunoassay was of value in suggesting the diagnosis. The patient responded to prednisone therapy with clinical and radiographic improvement and with a sharp decline in total serum IgE, and a lesser degree of decline in total serum IgG and IgA. Bronchopulmonary torulopsosis may be rare but should be considered in cases where the diagnosis of allergic bronchopulmonary aspergillosis cannot be established. Because IgE antibody could not be incriminated in this disease the term allergic bronchopulmonary torulopsosis was not used in this case.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201980     DOI: 10.1159/000233142

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Allergic bronchopulmonary mycosis due to Alternaria: Case report and review.

Authors:  Bhagteshwar Singh; David W Denning
Journal:  Med Mycol Case Rep       Date:  2012-03-03

Review 2.  Allergic bronchopulmonary aspergillosis.

Authors:  Paul A Greenberger; Robert K Bush; Jeffrey G Demain; Amber Luong; Raymond G Slavin; Alan P Knutsen
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

3.  Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88.

Authors:  S C Donnelly; H McLaughlin; C P Bredin
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.